These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 37744290)

  • 1. Developments and challenges in neoadjuvant therapy for locally advanced pancreatic cancer.
    Zhou B; Zhang SR; Chen G; Chen P
    World J Gastroenterol; 2023 Sep; 29(35):5094-5103. PubMed ID: 37744290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant Chemotherapy in Pancreatic Cancer: An Appraisal of the Current High-Level Evidence.
    Müller PC; Frey MC; Ruzza CM; Nickel F; Jost C; Gwerder C; Hackert T; Z'graggen K; Kessler U
    Pharmacology; 2021; 106(3-4):143-153. PubMed ID: 32966993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant therapy for pancreatic cancer.
    Gugenheim J; Crovetto A; Petrucciani N
    Updates Surg; 2022 Feb; 74(1):35-42. PubMed ID: 34628591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upfront Surgery and Surgery Following Neoadjuvant Treatment of Pancreatic Ductal Adenocarcinoma: A Comparative Analysis of Short-term Postoperative Outcomes.
    Jung JH; Yoon SK; Yoon SJ; Shin SH; Han IW; Heo JS
    Anticancer Res; 2021 Nov; 41(11):5703-5712. PubMed ID: 34732443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical issues in pathologic evaluation of pancreatic ductal adenocarcinoma resected after neoadjuvant treatment: a narrative review.
    Taherian M; Wang H
    Chin Clin Oncol; 2022 Jun; 11(3):21. PubMed ID: 35726190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study.
    Heinrich S; Besselink M; Moehler M; van Laethem JL; Ducreux M; Grimminger P; Mittler J; Lang H; Lutz MP; Lesurtel M;
    BMC Cancer; 2019 Jul; 19(1):675. PubMed ID: 31288786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term Outcomes.
    Harrison JM; Wo JY; Ferrone CR; Horick NK; Keane FK; Qadan M; Lillemoe KD; Hong TS; Clark JW; Blaszkowsky LS; Allen JN; Castillo CF
    Ann Surg Oncol; 2020 May; 27(5):1400-1406. PubMed ID: 31758284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma.
    Loehrer AP; Ferrone CR
    Dig Surg; 2016; 33(4):343-50. PubMed ID: 27216011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer.
    Truty MJ; Kendrick ML; Nagorney DM; Smoot RL; Cleary SP; Graham RP; Goenka AH; Hallemeier CL; Haddock MG; Harmsen WS; Mahipal A; McWilliams RR; Halfdanarson TR; Grothey AF
    Ann Surg; 2021 Feb; 273(2):341-349. PubMed ID: 30946090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of imaging in evaluating the response after neoadjuvant treatment for pancreatic ductal adenocarcinoma.
    Zhang Y; Huang ZX; Song B
    World J Gastroenterol; 2021 Jun; 27(22):3037-3049. PubMed ID: 34168406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian Approach to Understand the Association Between Treatment Down-staging and Survival for Patients With Pancreatic Adenocarcinoma.
    da Costa WL; Tran Cao HS; Gu X; Massarweh NN
    Ann Surg; 2022 Mar; 275(3):415-421. PubMed ID: 35120060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study.
    Lof S; Korrel M; van Hilst J; Alseidi A; Balzano G; Boggi U; Butturini G; Casadei R; Dokmak S; Edwin B; Falconi M; Keck T; Malleo G; de Pastena M; Tomazic A; Wilmink H; Zerbi A; Besselink MG; Abu Hilal M;
    Ann Surg Oncol; 2020 Jun; 27(6):1986-1996. PubMed ID: 31848815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide trends and outcomes of neoadjuvant chemotherapy in pancreatic cancer - an analysis of the Swedish national pancreatic cancer registry.
    Sternby H; Andersson B
    Scand J Gastroenterol; 2022 Nov; 57(11):1361-1366. PubMed ID: 35635264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal management of patients with operable pancreatic head cancer: A Markov decision analysis.
    Rieser CJ; Narayanan S; Bahary N; Bartlett DL; Lee KK; Paniccia A; Smith K; Zureikat AH
    J Surg Oncol; 2021 Oct; 124(5):801-809. PubMed ID: 34231222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go?
    Wang C; Tan G; Zhang J; Fan B; Chen Y; Chen D; Yang L; Chen X; Duan Q; Maimaiti F; Du J; Lin Z; Gu J; Luo H
    Front Oncol; 2022; 12():828223. PubMed ID: 35785193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant Treatment in Pancreatic Cancer.
    Oba A; Ho F; Bao QR; Al-Musawi MH; Schulick RD; Del Chiaro M
    Front Oncol; 2020; 10():245. PubMed ID: 32185128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging Assessment of Pancreatic Cancer Resectability After Neoadjuvant Therapy:
    Soloff EV; Al-Hawary MM; Desser TS; Fishman EK; Minter RM; Zins M
    AJR Am J Roentgenol; 2022 Apr; 218(4):570-581. PubMed ID: 34851713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing Post-Operative Outcomes of Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: Neoadjuvant Therapy Versus Surgery First Approach.
    Hyman DW; Almerey T; Mujkanovic A; Hammons I; Tice M; Stauffer JA
    Am Surg; 2022 Aug; 88(8):1868-1874. PubMed ID: 35465681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the management of pancreatic cancer: surgery is not enough.
    Ansari D; Gustafsson A; Andersson R
    World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives in the treatment of pancreatic adenocarcinoma.
    Cid-Arregui A; Juarez V
    World J Gastroenterol; 2015 Aug; 21(31):9297-316. PubMed ID: 26309356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.